Treatment of cancers with a novel combination of re-purposed pharmaceuticals and nutriceuticals.

Abstract

A 63 year old woman with CLL Leukemia offered to try a novel treatment being developed at our centre. Beginning with Propranolol and Aliskiren several additional compounds were tried over time, Aspirin, Curcumin and Bromelain were retained. Over the succeeding eight years her lymphocyte count has risen slowly and was presently stable around 35,000. A few weeks ago when Bromelain was increased to 500 mg pd the Lymphocytes dropped to 32.1. The patient still continues to lead a normal life with no side effects, the only complaint being tiredness. This treatment we infer to at, least, inhibit cancer growth.